Qualtec Co

Qualtec Co CapEx/OCF

The CapEx to Operating Cash Flow Ratio of Qualtec Co (9165.T) as of Oct 21, 2026 is 29.42 %. In the previous year, CapEx to Operating Cash Flow Ratio was 142.77 % — a change of -79.40% (lower).

CapEx/OCF

29.42 %

YoY

-79.40%

Last updated:

CapEx to Operating Cash Flow Ratio of Qualtec Co is 2026 29.42 % . CapEx to Operating Cash Flow Ratio of Qualtec Co was 2025 142.77 % . It decreases by -79.40% lower compared to the previous year.

The Qualtec Co CapEx/OCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

CapEx/OCF
Date
CapEx/OCF
Jan 1, 2021
14.39 JPY
Jan 1, 2022
24.55 JPY
Jan 1, 2023
90.92 JPY
Jan 1, 2024
58.68 JPY
Jan 1, 2025
142.77 JPY
Jan 1, 2026
29.42 JPY
The Qualtec Co CapEx/OCF history
YEARCapEx/OCFYoY
29.42 %-79.40%
142.77 %+143.32%
58.68 %-35.46%
90.92 %+270.35%
24.55 %+70.57%
14.39 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Qualtec Co Stock analysis

What does Qualtec Co do? Qualtec Co Ltd generates revenue through three business segments. The Reliability Evaluation Business segment sells testing machines and provides environmental, electrical, and vibration tests, including non-defective and defective product analysis. The Microfabrication Business segment offers laser processing services for build-up boards and flexible printed boards in both prototype and mass production. The Other Business segment delivers genetic mutation detection services for pets, contracted biomedical testing for packaging materials and syringes, and zero innovation consulting services. These services target industrial clients, veterinary clinics, and biomedical companies. The company's Reliability Evaluation segment serves manufacturers requiring product reliability validation. The Microfabrication segment caters to electronics manufacturers needing laser processing for circuit boards. The genetic testing services in the Other Business segment are sold to pet owners and veterinary clinics. Biomedical testing services target companies in the medical device industry. Zero innovation consulting is offered to businesses seeking technology and surface treatment solutions. Qualtec's product portfolio includes testing machines, laser processing services, genetic mutation detection, biomedical testing, and consulting services. The company's primary customers are electronics manufacturers, biomedical firms, veterinary clinics, and pet owners. These segments collectively serve industrial and healthcare markets with specialized technical services. Qualtec Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Qualtec Co stock

CapEx to Operating Cash Flow Ratio of Qualtec Co is 29.42 % in 2026.

CapEx to Operating Cash Flow Ratio of Qualtec Co changed from 142.77 % to 29.42 %, representing a -79.40% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of CapEx to Operating Cash Flow Ratio Qualtec Co since 2006 – with annual values, charts, and detailed analysis.

The CapEx/OCF ratio shows what percentage of operating cash flow is reinvested in capital assets. Lower ratios indicate more free cash available for shareholders.

A 'good' varies by industry and company stage. On Eulerpool, you can compare CapEx to Operating Cash Flow Ratio's Qualtec Co with sector peers and the industry average to assess whether it is attractive.

To evaluate CapEx to Operating Cash Flow Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for CapEx to Operating Cash Flow Ratio.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Qualtec Co

All Key Metrics — Qualtec Co